All Articles
By Colleen Hall
With specialty medicine comprising about half of all drug spending on the market in
the United States today, the concept of getting necessary prescriptions in the hands
of patients with life-threatening illnesses can, at times, seem daunting for providers, patients, and policymakers alike. Read More ›
Breastfeeding after receiving treatment for breast cancer is safe, and women who
have a germline BRCA mutation do not face an increased risk of recurrence or developing new breast cancers, according to data presented last month at the ESMO 2024 Congress. Read More ›
Immunotherapy continues to offer strong results in patients with advanced melanoma, according to data presented at the European Society for Medical Oncology (ESMO) 2024. Read More ›
Small cell lung cancer (SCLC) accounts for 15% of all lung cancer cases, with one-third of patients presenting with limited disease. Read More ›
Atezolizumab, in combination with carboplatin and etoposide, has received approval as the first-line therapy for patients diagnosed with extensive-stage small cell lung cancer, following the findings from the phase 1/3 IMpower133 trial (NCT02763579) Read More ›
Artificial intelligence holds promise for detecting lung cancer if research presented
last month at the IASLC 2024 World Conference on Lung Cancer is any indicator. Read More ›
Data presented at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer add another piece to the puzzle of people who have been diagnosed with lung cancer but have never smoked. Read More ›
The only tried and true method to achieve and maintain a successful revenue cycle
is through the careful creation of a strong foundation alongside attention to the
entire cycle. Read More ›
By Colleen Hall
While the panel acknowledged there is a long way to go in terms of encouraging diverse patient populations to participate in clinical trials, they note that there is reason for hope. Before the draft guidance was even issued by the FDA in June, several industry sponsors had already partnered with health care professionals to boost clinical trial participation. Read More ›
In recognition of Prostate and Ovarian Cancer Awareness months, we have
compiled a list of clinical trials in these areas to discuss with your patients. Read More ›